physIQ licenses virtual trial tech to Janssen in multi-year deal
pharmaphorum
APRIL 22, 2021
Biosensor firm physIQ has licensed its technology to Johnson & Johnson’s Janssen pharma unit in a multi-year deal, to investigate use of wearable sensors in virtual clinical trials. The pharma company will use the technology known as accelerateIQ to collect data across its clinical studies through a variety of wearable biosensors.
Let's personalize your content